• Monopar Therapeutics shares gain about 9.5% after immediate support holds above $100.45 Traders Union Thu, 09 Jul 2026 18:11:25 GMT
• What's behind Monopar Therapeutics's latest 11.6% stock surge? Traders Union Thu, 09 Jul 2026 16:27:28 GMT
• Form 144 Monopar Therapeutics Inc. For: 7 July By Investing.com Investing.com Nigeria Tue, 07 Jul 2026 19:10:56 GMT
• MNPR stock. Monopar Therapeutics stays tied to its clinical pipeline. AD HOC NEWS Tue, 07 Jul 2026 17:01:26 GMT
• Enterprise value to EBIT forward of Monopar Therapeutics Inc. – NASDAQ:MNPR TradingView Sat, 04 Jul 2026 08:27:03 GMT
• Monopar Therapeutics: ALXN1840's Bull Case Has Improved (NASDAQ:MNPR) Seeking Alpha Fri, 03 Jul 2026 14:10:15 GMT
• Form 4 Monopar Therapeutics Inc For: 2 July By Investing.com Investing.com Nigeria Fri, 03 Jul 2026 00:16:55 GMT
• Form 4 Monopar Therapeutics Inc For: 2 July By Investing.com Investing.com Canada Thu, 02 Jul 2026 23:46:51 GMT
• Monopar Therapeutics (MNPR) CFO nets shares from RSU vesting and tax withholding Stock Titan Thu, 02 Jul 2026 23:38:52 GMT
• Monopar Therapeutics (MNPR) CEO nets shares after RSU vesting and tax withholding Stock Titan Thu, 02 Jul 2026 23:38:23 GMT
• Monopar Therapeutics (MNPR) COO gains stock via RSU vesting and tax withholding Stock Titan Thu, 02 Jul 2026 23:38:06 GMT
• BTIG Maintains Monopar Therapeutics(MNPR.US) With Buy Rating, Maintains Target Price $117 富途牛牛 Wed, 01 Jul 2026 12:34:00 GMT
• Monopar Therapeutics price target raised to $117 from $104 at BTIG TipRanks Wed, 01 Jul 2026 11:47:00 GMT
• MNPR Q1 2026 Earnings: Significant EPS Beat Highlights Progress in Clinical Pipeline - Diluted EPS Report dars.gov.et Wed, 01 Jul 2026 07:00:00 GMT
• Form 4 Monopar Therapeutics Inc For: 30 June By Investing.com Investing.com Nigeria Tue, 30 Jun 2026 21:53:15 GMT
• Monopar Therapeutics (MNPR) Receives FDA Rare Pediatric Disease Designation GuruFocus Tue, 30 Jun 2026 13:44:27 GMT
• btig maintains monopar therapeutics(mnpr.us) with buy rating, raises target price to $117 Moomoo Tue, 30 Jun 2026 13:31:00 GMT
• Monopar gets rare pediatric disease tag for Wilson treatment Investing.com Tue, 30 Jun 2026 12:42:47 GMT
• monopar stock jumps after fda rare pediatric disease tag Investing.com Tue, 30 Jun 2026 12:35:45 GMT
• Monopar Therapeutics Receives FDA Rare Pediatric Disease Designation for ALXN1840 for the Treatment of Wilson Disease The Manila Times Tue, 30 Jun 2026 12:03:50 GMT
• monopar therapeutics price target raised to $117 from $104 at btig TipRanks Tue, 30 Jun 2026 11:51:01 GMT
• wall street analysts are bullish on top healthcare picks The Globe and Mail Tue, 30 Jun 2026 11:45:00 GMT
• Monopar Therapeutics (MNPR) director Nicole Sweeny files initial Form 3 Stock Titan Tue, 30 Jun 2026 07:00:00 GMT
• BTIG raises Monopar Therapeutics price target on regulatory outlook Investing.com Tue, 30 Jun 2026 07:00:00 GMT
• Monopar Therapeutics (MNPR) director granted 1,284 stock options Stock Titan Tue, 30 Jun 2026 07:00:00 GMT
• FDA rare pediatric disease tag could speed ALXN1840’s path for Wilson disease Stock Titan Tue, 30 Jun 2026 07:00:00 GMT
• FDA grants Rare Pediatric Disease designation to Monopar (MNPR) Wilson disease drug ALXN1840 Stock Titan Tue, 30 Jun 2026 07:00:00 GMT
• Lake Street Maintains Monopar Therapeutics(MNPR.US) With Buy Rating, Maintains Target Price $103 Moomoo Tue, 30 Jun 2026 07:00:00 GMT
• jonestrading maintains monopar therapeutics(mnpr.us) with buy rating, maintains target price $130 富途牛牛 Mon, 29 Jun 2026 21:48:05 GMT
• +8.47% for Monopar Therapeutics stock as buyers push price above key averages Traders Union Mon, 29 Jun 2026 21:21:38 GMT
• monopar therapeutics inc actuals & estimates (nasdaq:mnpr) TradingView Mon, 29 Jun 2026 18:36:55 GMT
• Companies Like Monopar Therapeutics (NASDAQ:MNPR) Can Afford To Invest In Growth Moomoo Mon, 29 Jun 2026 16:55:53 GMT
• Monopar Therapeutics Inc.(NasdaqCM: MNPR) added to Russell 2000 Value Benchmark marketscreener.com Mon, 29 Jun 2026 15:16:38 GMT
• Monopar Therapeutics Inc.(NasdaqCM:MNPR) added to Russell Microcap Value Benchmark Index marketscreener.com Mon, 29 Jun 2026 13:31:56 GMT
• A Quick Look at Today's Ratings for Monopar Therapeutics(MNPR.US), With a Forecast Between $101 to $130 富途牛牛 Mon, 29 Jun 2026 13:00:00 GMT
• MNPR Reiterates by HC Wainwright & Co. -- Price Target Maintained at $105 GuruFocus Mon, 29 Jun 2026 12:11:03 GMT
• Monopar Therapeutics Insiders Make Handsome Sum Selling Stock At US$67.15 Per Share simplywall.st Mon, 29 Jun 2026 07:00:00 GMT
• H.C. Wainwright reiterates Monopar stock rating on trial data Investing.com Mon, 29 Jun 2026 07:00:00 GMT
• price to earnings forward of monopar therapeutics inc. – nasdaq:mnpr TradingView Mon, 29 Jun 2026 05:26:53 GMT
• price to book forward of monopar therapeutics inc. – nasdaq:mnpr TradingView Mon, 29 Jun 2026 04:30:51 GMT
• price to book forward of monopar therapeutics inc – gettex:1iy0 TradingView Mon, 29 Jun 2026 00:57:54 GMT
• Monopar Therapeutics Inc.(NasdaqCM:MNPR) added to Russell Small Cap Comp Value Benchmark marketscreener.com Sun, 28 Jun 2026 07:00:00 GMT
• Monopar Therapeutics Inc.(NasdaqCM: MNPR) added to Russell 3000 Value Benchmark marketscreener.com Sun, 28 Jun 2026 07:00:00 GMT
• Price to sales forward of Monopar Therapeutics Inc – GETTEX:1IY0 TradingView Sun, 28 Jun 2026 00:11:38 GMT
• monopar therapeutics inc actuals & estimates (nasdaq:mnpr) TradingView Sat, 27 Jun 2026 00:52:22 GMT
• monopar plans mid-2026 nda filing for wilson disease drug Investing.com Fri, 26 Jun 2026 23:46:58 GMT
• Monopar Therapeutics (MNPR) to Present New Data on ALXN1840 at E GuruFocus Fri, 26 Jun 2026 20:55:37 GMT
• Monopar Presents Phase 3 FoCus Data Showing Neurologic and Global Benefit with ALXN1840 TradingView Fri, 26 Jun 2026 20:13:01 GMT
• monopar’s wilson disease drug shows stronger neurologic gains in phase 3 Stock Titan Fri, 26 Jun 2026 20:05:00 GMT
• monopar therapeutics inc actuals & estimates (ls:a40jml) TradingView Fri, 26 Jun 2026 18:36:45 GMT
• Monopar Presents New Analyses of Phase 3 FoCus Data at EAN 2026 Showing Greater Neurologic and Global Clinical Benefit with ALXN18... Yahoo Finance Fri, 26 Jun 2026 07:00:00 GMT
• ALXN1840 Phase 3 data back NDA plan for Wilson disease, Monopar (NASDAQ: MNPR) Stock Titan Fri, 26 Jun 2026 07:00:00 GMT
• NDA submission progress for ALXN1840 in Wilson disease sends Monopar Therapeutics stock up 7.61% Traders Union Wed, 24 Jun 2026 07:00:00 GMT
• monopar therapeutics inc (mnpr) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 24 Jun 2026 07:00:00 GMT
• Monopar Shareholders Approve Directors, Pay and Incentive Plan TipRanks Tue, 23 Jun 2026 13:07:43 GMT
• Monopar Therapeutics shareholders approve all proposals at annual meeting By Investing.com Investing.com Canada Tue, 23 Jun 2026 12:45:54 GMT
• monopar therapeutics 8-k filing: annual meeting results, stock incentive plan approval, and key sec information Minichart Tue, 23 Jun 2026 12:25:00 GMT
• free cash flow per share of monopar therapeutics inc – dus:1iy0 TradingView Tue, 23 Jun 2026 10:44:24 GMT
• Monopar (NASDAQ: MNPR) meeting backs board, pay and 2026 plan Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• near-term momentum pushes monopar therapeutics stock up 7.19% Traders Union Tue, 23 Jun 2026 07:00:00 GMT
• strong demand pushes monopar therapeutics stock higher in an extended rally Traders Union Mon, 22 Jun 2026 17:36:12 GMT
• why (mnpr) price action is critical for tactical trading Stock Traders Daily Sun, 21 Jun 2026 06:30:01 GMT
• Monopar Therapeutics stock gains 3.15% as price finishes near session high Traders Union Fri, 19 Jun 2026 07:00:00 GMT
• basic earnings per share (basic eps) of monopar therapeutics inc – dus:1iy0 TradingView Thu, 18 Jun 2026 21:03:27 GMT
• Monopar Therapeutics Stock - Thursday chart and volatility snapshot AD HOC NEWS Thu, 18 Jun 2026 16:40:32 GMT
• Monopar Therapeutics Inc (MNPR) Financial Health: Profitability & Balance Sheet Analysis TradingKey Thu, 18 Jun 2026 09:56:22 GMT
• monopar therapeutics inc (mnpr) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 06:53:20 GMT
• Monopar Therapeutics Inc (MNPR) Technical Analysis: Support, Resistance, Indicators & Moving Averages TradingKey Thu, 18 Jun 2026 06:22:30 GMT
• monopar therapeutics inc (mnpr) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 06:22:27 GMT
• monopar therapeutics inc (mnpr) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 06:22:25 GMT
• Wall Street Analysts Believe Monopar Therapeutics (MNPR) Could Rally 88.92%: Here's is How to Trade MSN Wed, 17 Jun 2026 12:29:13 GMT
• Monopar Therapeutics Inc (MNPR) Dividends & Stock Splits: Historical Payouts and Event Timeline TradingKey Wed, 17 Jun 2026 08:47:17 GMT
• monopar therapeutics inc (mnpr) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 05:56:03 GMT
• monopar therapeutics inc (mnpr) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 05:50:16 GMT
• monopar therapeutics stock price forecast: $66.1636 resistance in focus as mnpr climbs 3.12% Traders Union Tue, 16 Jun 2026 07:00:00 GMT
• wall street analysts believe monopar therapeutics (mnpr) could rally 88.92%: here's is how to trade Zacks Investment Research Tue, 16 Jun 2026 02:58:29 GMT
• Wall Street Analysts Believe Monopar Therapeutics (MNPR) Could Rally 88.92%: Here's is How to Trade Yahoo Finance Mon, 15 Jun 2026 07:00:00 GMT
• mnpr q1 2026 earnings: narrowed loss beats estimates as pipeline progress continues - consensus forecast report dars.gov.et Mon, 15 Jun 2026 07:00:00 GMT
• monopar therapeutics q1 2026 earnings: smaller-than-expected loss as eps surprises positively - revenue guidance update newsline.com Fri, 12 Jun 2026 20:37:31 GMT
• monopar therapeutics (mnpr) climbs nearly 2%, approaches key resistance at $63.64 - inside day breakout newsline.com Mon, 08 Jun 2026 21:43:35 GMT
• mnpr q1 2026 earnings: eps beat on lower net loss - earnings deceleration risk dars.gov.et Mon, 08 Jun 2026 07:00:00 GMT
• h.c. wainwright maintains monopar therapeutics(mnpr.us) with buy rating, maintains target price $105 Moomoo Wed, 03 Jun 2026 10:31:00 GMT
• piper sandler maintains monopar therapeutics(mnpr.us) with buy rating, maintains target price $101 Moomoo Wed, 03 Jun 2026 07:00:00 GMT
• monopar therapeutics inc (mnpr) receives a buy from piper sandler The Globe and Mail Wed, 03 Jun 2026 07:00:00 GMT
• lake street keeps their buy rating on monopar therapeutics inc (mnpr) The Globe and Mail Tue, 02 Jun 2026 14:32:00 GMT
• a quick look at today's ratings for monopar therapeutics(mnpr.us), with a forecast between $101 to $105 Moomoo Tue, 02 Jun 2026 07:00:00 GMT
• analysts are bullish on top healthcare stocks: monopar therapeutics inc (mnpr), gossamer bio (goss) The Globe and Mail Tue, 02 Jun 2026 07:00:00 GMT
• monopar therapeutics stock declines as late-session selling erases earlier gains Traders Union Tue, 02 Jun 2026 07:00:00 GMT
• mnpr q1 2026 earnings: narrower-than-expected loss highlights cost discipline - final results newsline.com Tue, 02 Jun 2026 07:00:00 GMT
• monopar: buy rating reiterated as alxn1840 data underpin valuation and $104 price target maintained TipRanks Tue, 02 Jun 2026 07:00:00 GMT
• mnpr stock price, quote & chart | monopar therapeutics inc (nasdaq:mnpr) ChartMill Tue, 02 Jun 2026 00:29:37 GMT
• monopar therapeutics (mnpr) showcases promising phase 2 results at easl congress 2026 GuruFocus Mon, 01 Jun 2026 19:51:46 GMT
• monopar therapeutics presents phase 2 data for alxn1840 at easl congress 2026, demonstrating liver disease stabilization and neuro... Quiver Quantitative Mon, 01 Jun 2026 07:00:00 GMT
• monopar presents phase 2 alxn1840 data demonstrating liver disease stabilization and neurologic improvement in treatment-experienc... Yahoo Finance Mon, 01 Jun 2026 07:00:00 GMT
• monopar presents phase 2 data on wilson disease treatment Investing.com Mon, 01 Jun 2026 07:00:00 GMT
• mnpr stock price, quote & chart | monopar therapeutics inc (nasdaq:mnpr) ChartMill Mon, 01 Jun 2026 07:00:00 GMT
• monopar therapeutics presents phase 2 results of alxn1840 (tiomolibdate choline) for wilson disease at easl international liver co... Minichart Sun, 31 May 2026 10:02:00 GMT
• MNPR Q1 2026 Earnings: Loss Narrower Than Expected, Stock Rises on Positive Surprise - Earnings Analysis dars.gov.et Sun, 31 May 2026 07:00:00 GMT
• mnpr q1 2026 earnings: narrower-than-expected loss as early-stage biotech advances radiopharmaceutical pipeline - revenue report newsline.com Sun, 31 May 2026 06:42:44 GMT
• avoiding lag: real-time signals in (mnpr) movement Stock Traders Daily Sat, 30 May 2026 03:52:01 GMT
• Monopar Therapeutics (MNPR) shares Phase 2 Wilson disease data at EASL 2026 Stock Titan Fri, 29 May 2026 07:00:00 GMT
• monopar therapeutics stock (us6093601054): low-volume nasdaq trading as investors await next catalys AD HOC NEWS Fri, 29 May 2026 07:00:00 GMT
• monopar therapeutics shares dip amid rising selling pressure Traders Union Fri, 29 May 2026 07:00:00 GMT
• monopar therapeutics (mnpr) holds steady at $64.43: slight decline signals consolidation - investment factor The Legal Advocate Fri, 29 May 2026 02:31:40 GMT
• what triggered monopar therapeutics shares' latest price surge Traders Union Thu, 28 May 2026 19:09:43 GMT
• Monopar Therapeutics (MNPR) Holds Steady at $64.43: Slight Decline Signals Consolidation - BPI Bear Confirmed dars.gov.et Thu, 28 May 2026 07:00:00 GMT
• Monopar Therapeutics (MNPR) Surges 3% as Biotech Momentum Builds, Tests Key Resistance - Reversal Trade dars.gov.et Wed, 27 May 2026 07:00:00 GMT
• monopar therapeutics stock rises as short-term exhaustion signals surface after recent rally Traders Union Wed, 27 May 2026 07:00:00 GMT
• monopar therapeutics (mnpr) news today: latest market and industry updates Traders Union Tue, 26 May 2026 16:24:25 GMT
• Monopar Therapeutics stock price forecast: Holding $60.25 support as MNPR declines 2.47% Traders Union Tue, 26 May 2026 07:00:00 GMT
• what triggered monopar therapeutics shares' latest price pullback Traders Union Tue, 26 May 2026 05:22:15 GMT
• mnpr q1 2026 earnings: narrower-than-expected loss reflects controlled spending; stock edges higher The Legal Advocate Sat, 23 May 2026 21:40:48 GMT
• monopar therapeutics q1 2026 earnings: narrower loss surprises market - earnings momentum score newsline.com Sat, 23 May 2026 07:00:00 GMT
• MNPR Q1 2026 Earnings: Surprise EPS Beat in Pre-Revenue Biotech - Net Income Trends dars.gov.et Fri, 22 May 2026 07:00:00 GMT
• monopar therapeutics stock (us6093601054): experimental drug update and cash runway spark fresh inve AD HOC NEWS Thu, 21 May 2026 07:00:00 GMT
• monopar announces publication of phase 2 study demonstrating alxn1840 significantly improves copper balance in patients with wilso... The Manila Times Wed, 20 May 2026 07:00:00 GMT
• monopar therapeutics presents positive phase 2 results for alxn1840 in wilson disease patients Minichart Wed, 20 May 2026 07:00:00 GMT
• monopar reports positive wilson disease trial data publication by investing.com Investing.com South Africa Wed, 20 May 2026 00:51:51 GMT
• monopar announces publication of phase 2 study demonstrating alxn1840 significantly improves copper balance in patients with wilso... The Manila Times Tue, 19 May 2026 21:44:33 GMT
• monopar therapeutics inc announces publication of phase 2 study demonstrating alxn1840 significantly improves copper balance in pa... marketscreener.com Tue, 19 May 2026 21:33:00 GMT
• chardan capital initiates coverage of monopar therapeutics (mnpr) with buy recommendation MSN Tue, 19 May 2026 21:13:28 GMT
• alxn1840 wilson disease trial data published by monopar (nasdaq: mnpr) Stock Titan Tue, 19 May 2026 07:00:00 GMT
• monopar therapeutics publishes phase 2 trial results of alxn1840 for wilson disease in hepatology communications Quiver Quantitative Tue, 19 May 2026 07:00:00 GMT
• drug trial helps wilson disease patients shed excess copper Stock Titan Tue, 19 May 2026 07:00:00 GMT
Monopar Therapeutics Inc(NASDAQ:MNPR) 
Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing proprietary therapeutics to enhance clinical outcomes for cancer patients in the United States. It is involved in developing Validive, a clonidine mucobuccal tablet that is in Phase 2b/3 clinical trial for t...
Website: https://www.monopartx.com/
Founded: 2014
Full Time Employees: 6
CEO: Chandler Drew Robinson
Sector: Healthcare
Industry: Biotechnology